or is the enrollment going to cause a delay in phase 2 results?
havent been investing since then. probably a bad time to jump back into the market but do you know anything about this stock?
What is up with this company? looking to purchase shares here. any longs? I see middle of 2016 to be a key potential time for the top drug candidate's trial? Just looking for some dialogue.